ION Launches as Australia's New Hub for Life Sciences Innovation with Global Partnerships
ION secures first global partners, advancing Australia's next generation of life sciences innovation
Image: Medical News
Australia's life sciences sector takes a significant step forward with the announcement of ION, a specialized commercial precinct in Waterloo, Sydney. Backed by partners SmartLabs, International Workplace Group, and Thermo Fisher Scientific, ION aims to enhance infrastructure for biotech and pharmaceutical firms, with an investment of approximately $490 million.
- 01ION will provide over 27,000 sqm of lab-enabled space across a multi-building precinct, addressing the shortage of specialized life sciences infrastructure in Australia.
- 02The project introduces SmartLabs' 'lab-as-a-service' model to Australia, offering flexible laboratory environments without heavy upfront costs.
- 03Kurraba Group's CEO Nick Smith emphasized that ION aims to facilitate faster translation of research into real-world applications.
- 04The precinct is strategically located within Sydney's health and research ecosystem, enhancing Australia's capability to retain intellectual property and attract global investment.
- 05Construction is set to begin soon, with completion targeted for Q4 2028.
Advertisement
In-Article Ad
Sydney's life sciences sector is poised for transformation with the launch of ION, a dedicated commercial precinct in Waterloo designed to support biotech, medtech, and pharmaceutical companies. Announced by Kurraba Group, ION has secured its first partners: SmartLabs, International Workplace Group (IWG), and Thermo Fisher Scientific, representing a combined investment of approximately $490 million. The precinct will feature over 27,000 sqm of lab-enabled space across multiple buildings, addressing a critical shortage in specialized infrastructure. A key feature is the introduction of SmartLabs' 'lab-as-a-service' model, which provides flexible laboratory environments to reduce entry barriers for high-growth scientific organizations. Nick Smith, CEO of Kurraba Group, highlighted the project's potential to accelerate the commercialization of research. With construction set to commence soon and completion expected by Q4 2028, ION is positioned to become a vital component of Australia's innovation ecosystem, fostering collaboration and supporting the growth of local life sciences companies.
Advertisement
In-Article Ad
ION is expected to significantly enhance the infrastructure available for life sciences companies in Australia, facilitating faster commercialization of research.
Advertisement
In-Article Ad
Reader Poll
What aspect of the ION project excites you the most?
Connecting to poll...
Read the original article
Visit the source for the complete story.